Article
Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Dec 2013
Carey Elizabeth J, Iyer Vivek N, Nelson Darlene R, Nguyen Justin H, Krowka Michael J
Abstract excerpt
Alpha-1-antitrypsin (AAT) deficiency is a rare genetic disease caused by an abnormal production of the serine protease inhibitor AAT. Liver transplantation (LT) cures cirrhosis caused by AAT deficiency and restores the normal production of AAT. There are few reports on the post-LT outcomes of patients with AAT deficiency. The aim of this study was to determine the characteristics and outcomes of patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
